Altamira Therapeutics Ltd. (CYTO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Altamira Therapeutics Ltd...

    NASDAQ: CYTO · Real-Time Price · USD
    0.30
    0.00 (0.00%)
    At close: Jan 16, 2025, 10:00 PM

    Altamira Therapeutics Balance Sheet Statement

    Financials in CHF. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 617.41K 15.39K 984.19K
    Short-Term Investments
    		 n/a n/a n/a
    Long-Term Investments
    		 2.5M 194.26K 199.1K
    Other Long-Term Assets
    		 n/a -4.53M -15.08M
    Receivables
    		 74.82K 6.53K 21.75K
    Inventory
    		 n/a 11.64K 839.22K
    Other Current Assets
    		 247.09K 270.18K 671.34K
    Total Current Assets
    		 1.22M 1.77M 3.76M
    Property-Plant & Equipment
    		 80.11K 445.83K 564.72K
    Goodwill & Intangibles
    		 3.89M 3.89M 14.31M
    Total Long-Term Assets
    		 6.47M 4.53M 15.08M
    Total Assets
    		 7.69M 6.3M 18.84M
    Account Payables
    		 413.11K 4.77M 3.54M
    Deferred Revenue
    		 n/a n/a n/a
    Short-Term Debt
    		 n/a 5.87M n/a
    Other Current Liabilities
    		 190.61K 362.5K 196.92K
    Total Current Liabilities
    		 888.91K 12.88M 4.86M
    Long-Term Debt
    		 n/a n/a n/a
    Other Long-Term Liabilities
    		 346.63K 1.39M 812.04K
    Total Long-Term Liabilities
    		 346.63K 1.74M 1.27M
    Total Liabilities
    		 1.24M 14.62M 6.13M
    Total Debt
    		 99.66K 6.33M 575.74K
    Common Stock
    		 2.65K 236.01K 149.64K
    Retained Earnings
    		 -18.05M -201.43M -176.02M
    Comprehensive Income
    		 177.58K 258.04K 62.07K
    Shareholders Equity
    		 6.46M -8.31M 12.7M
    Total Investments
    		 2.5M 194.26K 199.1K

    Add to Watchlist